Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nabil A. Elshafeey"'
Autor:
Zijian Zhou, Beatriz E. Adrada, Rosalind P. Candelaria, Nabil A. Elshafeey, Medine Boge, Rania M. Mohamed, Sanaz Pashapoor, Jia Sun, Zhan Xu, Bikash Panthi, Jong Bum Son, Mary S. Guirguis, Miral M. Patel, Gary J. Whitman, Tanya W. Moseley, Marion E. Scoggins, Jason B. White, Jennifer K. Litton, Vicente Valero, Kelly K. Hunt, Debu Tripathy, Wei Yang, Peng Wei, Clinton Yam, Mark D. Pagel, Gaiane M. Rauch, Jingfei Ma
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Neoadjuvant systemic therapy (NAST) followed by surgery are currently standard of care for TNBC with 50-60% of patients achieving pathologic complete response (p
Externí odkaz:
https://doaj.org/article/9d1afc4d0a46451ea11ba6d0e3bea0a2
Autor:
Zijian Zhou, Nabil A Elshafeey, David E Rauch, Beatriz E Adrada, Rosalind P Candelaria, Mary S Guirguis, Wei Yang, Medine Boge, Rania M Mohamed, Gary J Whitman, Deanna L Lane, Huong C Le-Petross, Jessica WT Leung, Lumarie Santiago, Marion E Scoggins, David A Spak, Miral M Patel, Frances Perez, Debu Tripathy, Vicente Valero, Clinton Yam, Stacy Moulder, Jason B White, Jong Bum Son, Mark D Pagel, Jingfei Ma
Publikováno v:
Cancer Research. 82:P1-08
Introduction: Neoadjuvant chemotherapy (NACT) is becoming standard of care for presurgical treatment of triple negative breast cancer (TNBC) patients. Achievement of pathological complete response (pCR) after NACT is associated with improved outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d962b3471b2141ef4e860540dd340178
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-03
https://doi.org/10.1158/1538-7445.sabcs21-p1-08-03
Autor:
Benjamin C. Musall, Beatriz E. Adrada, Rosalind P. Candelaria, Rania M. M. Mohamed, Abeer H. Abdelhafez, Jong Bum Son, Jia Sun, Lumarie Santiago, Gary J. Whitman, Tanya W. Moseley, Marion E. Scoggins, Hagar S. Mahmoud, Jason B. White, Ken‐Pin Hwang, Nabil A. Elshafeey, Medine Boge, Shu Zhang, Jennifer K. Litton, Vicente Valero, Debu Tripathy, Alastair M. Thompson, Clinton Yam, Peng Wei, Stacy L. Moulder, Mark D. Pagel, Wei T. Yang, Jingfei Ma, Gaiane M. Rauch
Publikováno v:
Journal of magnetic resonance imaging : JMRIReferences. 56(6)
Pathologic complete response (pCR) to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC) is a strong predictor of patient survival. Edema in the peritumoral region (PTR) has been reported to be a negative prognostic factor in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d1afce6bff9f4ab2020cdc51d1e71c
https://pubmed.ncbi.nlm.nih.gov/35506513
https://pubmed.ncbi.nlm.nih.gov/35506513
Autor:
Mary S Guirguis, Beatriz E Adrada, Rosalind P Candelaria, Jia Sun, Gary J Whitman, Wei T Yang, Medine Boge, Rania M Mohamed, Nabil A Elshafeey, Deanna L Lane, Huong Le-Petross, Jessica WT Leung, Lumarie Santiago, Marion E Scoggins, David A Spak, Miral Patel, Frances Perez, Peng Wei, Debu Tripathy, Jason White, Elizabeth Ravenberg, Lei Huo, Jennifer Litton, Banu Arun, Vincente Valero, Alastair Thompson, Stacy Moulder, Clinton Yam, Gaiane M Rauch
Publikováno v:
Cancer Research. 82:P3-03
Background: Triple negative breast cancer (TNBC) has a poor prognosis. In particular, TNBC patients who have significant residual disease at the time of surgery following completion of neoadjuvant systemic therapy (NST) have an especially poor progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc8bec0e29c56689ce0466309b02e006
https://doi.org/10.1158/1538-7445.sabcs21-p3-03-06
https://doi.org/10.1158/1538-7445.sabcs21-p3-03-06